Bogle Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bogle Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,108	Closed	-$490K	–	285
2018 Q4	$490K	Buy	+2,108	New	+$566K	0.04%	277
2015 Q4	–	Sell	-11,674	Closed	-$1.57M	–	379
2015 Q3	$1.57M	Sell	11,674 -41,792	-78%	-$6.01M	0.11%	210
2015 Q2	$8.05M	Buy	53,466 +49,501	+1,248%	+$7.08M	0.6%	58
2015 Q1	$535K	Hold	3,965	–	–	0.04%	289
2014 Q4	$478K	Sell	3,965 -11,714	-75%	-$1.35M	0.03%	301
2014 Q3	$1.78M	Buy	+15,679	New	+$1.86M	0.12%	193
2013 Q3	–	Sell	-31,919	Closed	-$3.58M	–	308
2013 Q2	$3.58M	Buy	+31,919	New	+$3.74M	0.44%	98

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bogle Investment Management's BIO Position: Q1 2019 in Review

Bogle Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2019, closing a stake of 2,108 shares — an estimated $490K sold.

Bogle Investment Management first reported a position in BIO in Q2 2013 and held it in 7 quarters. The position peaked at $8.05M in Q2 2015. 346 funds tracked by Wall St. Rank hold BIO as of Q1 2019.

Bogle Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2019 after selling out during the quarter.
Bogle Investment Management sold 2,108 Bio-Rad Laboratories Class A shares in Q1 2019, an estimated $490K.
Bogle Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 7 quarters.
Bogle Investment Management's Bio-Rad Laboratories Class A position peaked at $8.05M in Q2 2015.
346 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.